Article Versions Notes

Koga Y, Hachisu Y, Tsurumaki H, Yatomi M, Kaira K, Ohta S, Ono J, Izuhara K, Dobashi K, Hisada T. Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels. Medicina. 2019; 55(5):161. https://doi.org/10.3390/medicina55050161

Koga, Yasuhiko, Yoshimasa Hachisu, Hiroaki Tsurumaki, Masakiyo Yatomi, Kyoichi Kaira, Shoichiro Ohta, Junya Ono, Kenji Izuhara, Kunio Dobashi, and Takeshi Hisada. 2019. "Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels" Medicina 55, no. 5: 161. https://doi.org/10.3390/medicina55050161

Koga, Y., Hachisu, Y., Tsurumaki, H., Yatomi, M., Kaira, K., Ohta, S., Ono, J., Izuhara, K., Dobashi, K., & Hisada, T. (2019). Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels. Medicina, 55(5), 161. https://doi.org/10.3390/medicina55050161